Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody
Clinical trial NCT02189837 · COMPLETED
Trial details
- NCT number
- NCT02189837
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-08
- Primary completion
- 2015-02-13
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.